Advanced search
Publication Cover
Leukemia & Lymphoma Volume 56, 2015 - Issue 3
Submit an article Journal homepage
220
Views
15
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Prognostic impact of β2-microglobulin in patients with non-gastric mucosa-associated lymphoid tissue lymphoma

Changhoon YooDepartment of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
,
Dok Hyun YoonDepartment of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
,
Shinkyo YoonDepartment of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
,
Shin KimDepartment of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
,
Jooryung HuhDepartment of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
,
Chan-Jeong ParkDepartment of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
,
Sang-Wook LeeDepartment of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
&
Cheolwon SuhDepartment of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, KoreaCorrespondence[email protected]
 show all
Pages 688-693 | Received 25 Feb 2014, Accepted 19 Apr 2014, Published online: 17 Jul 2014

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Hyung-Don Kim, Hyungwoo Cho, Byeong Seok Sohn, Chan-Sik Park, Jooryung Huh, Jin Sook Ryu, Sang-Wook Lee, Sang Eun Yoon, Seok Jin Kim, Young Hyeh Ko, Won Seog Kim & Cheolwon Suh. (2022) Prognostic significance of serum β2-microglobulin levels in patients with peripheral T-cell lymphoma not otherwise specified. Leukemia & Lymphoma 63:1, pages 124-130.
Read now
Barbara Kiesewetter & Markus Raderer. (2021) How can we assess and measure prognosis for MALT lymphoma? A review of current findings and strategies. Expert Review of Hematology 14:4, pages 391-399.
Read now

Articles from other publishers (13)

Xiaosheng Li, Yue Chen, Anlong Sun, Ying Wang, Yao Liu & Haike Lei. (2023) Development and validation of prediction model for overall survival in patients with lymphoma: a prospective cohort study in China. BMC Medical Informatics and Decision Making 23:1.
Crossref
Jae‐Hyeon Im, Su‐Min Park, Ju‐Hyun An, Tea‐Hee Kim, Hyung‐Kyu Chae, Ye‐In Oh, Kyoung‐Won Seo & Hwa‐Young Youn. (2023) Evaluation of serum interleukin 2 receptor and beta‐2‐microglobulin as prognostic factors for canine lymphoma: A pilot study. Veterinary and Comparative Oncology 21:2, pages 184-190.
Crossref
Xin Zhang, Yang Han, Yu Nie, Yujie Jiang, Xiaohui Sui, Xueling Ge, Fang Liu, Ya Zhang & Xin Wang. (2023) PAX5 aberrant expression incorporated in MIPI-SP risk scoring system exhibits additive value in mantle cell lymphoma. Journal of Molecular Medicine 101:5, pages 595-606.
Crossref
Ning-Chun Chen, Hung Chang, Hsiao-Wen Kao, Che-Wei Ou, Ming-Chung Kuo, Po-Nan Wang, Tung-Liang Lin, Jin-Hou Wu, Yu-Shin Hung, Yi-Jiun Su, Yuen-Chin Ong & Hsuan-Jen Shih. (2023) Beta2-microglobulin is a valuable marker and identifies a poor-prognosis subgroup among intermediate-risk patients with diffuse large B cell lymphoma. Clinical and Experimental Medicine 23:7, pages 3759-3766.
Crossref
Hyung‐Don Kim, Hyungwoo Cho, Hyehyun Jeong, Kyunghye Bang, Shin Kim, Kyoungmin Lee, Eun Hee Kang, Jung Sun Park, Chan‐Sik Park, Jooryung Huh, Jin‐Sook Ryu, Sang‐Wook Lee, Dok Hyun Yoon, Sung Yong Oh & Cheolwon Suh. (2020) A prognostic index for extranodal marginal‐zone lymphoma based on the mucosa‐associated lymphoid tissue International Prognostic Index and serum β2‐microglobulin levels. British Journal of Haematology 193:2, pages 307-315.
Crossref
Yufeng Shang, Xiaorui Fu, Yu Chang, Yanan Li & Mingzhi Zhang. (2018) B2 microglobulin is a novel prognostic marker of Angioimmunoblastic T-cell lymphoma. Scientific Reports 8:1.
Crossref
Yusuke Kanemasa, Tatsu Shimoyama, Yuki Sasaki, Miho Tamura, Takeshi Sawada, Yasushi Omuro, Tsunekazu Hishima & Yoshiharu Maeda. (2017) Beta-2 microglobulin as a significant prognostic factor and a new risk model for patients with diffuse large B-cell lymphoma. Hematological Oncology 35:4, pages 440-446.
Crossref
Junshik Hong, Seok Jin Kim, Myung Hee Chang, Jeong-A Kim, Jae-Yong Kwak, Jin Seok Kim, Dok Hyun Yoon, Won Sik Lee, Young Rok Do, Hye Jin Kang, Hyeon-Seok Eom, Yong Park, Jong-Ho Won, Yeung-Chul Mun, Hyo Jung Kim, Jung Hye Kwon, Jee Hyun Kong, Sung Yong Oh, Sunah Lee, Sung Hwa Bae, Deok-Hwan Yang, Hyun Jung Jun, Ho Sup Lee, Hwan Jung Yun, Soon Il Lee, Min Kyoung Kim, Jun Ho Yi, Jae Hoon Lee, Won Seog Kim & Cheolwon Suh. (2017) Improved prognostic stratification using NCCN- and GELTAMO-international prognostic index in patients with diffuse large B-cell lymphoma. Oncotarget 8:54, pages 92171-92182.
Crossref
Jihoon KangShinkyo YoonCheolwon Suh. (2017) Relevance of prognostic index with β2-microglobulin for patients with diffuse large B-cell lymphoma in the rituximab era. Blood Research 52:4, pages 276.
Crossref
Seyoung Seo, Jung Yong Hong, Shinkyo Yoon, Changhoon Yoo, Ji Hyun Park, Jung Bok Lee, Chan-sik Park, Jooryung Huh, Yoonse Lee, Kyung Won Kim, Jin-Sook Ryu, Seok Jin Kim, Won Seog Kim, Dok Hyun Yoon & Cheolwon Suh. (2016) Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era. Oncotarget 7:47, pages 76934-76943.
Crossref
Changhoon Yoo, Dok Hyun Yoon, Shin Kim, Jooryung Huh, Chan-Sik Park, Chan-Jeong Park, Sang-Wook Lee & Cheolwon Suh. (2016) Serum beta-2 microglobulin as a prognostic biomarker in patients with mantle cell lymphoma. Hematological Oncology 34:1, pages 22-27.
Crossref
SM Ouda, AM Khairy, Ashraf E Sorour & Mikhail Nasr Mikhail. (2015) Serum Beta-2 Microglobulin: a Possible Marker for Disease Progression in Egyptian Patients with Chronic HCV Related Liver Diseases. Asian Pacific Journal of Cancer Prevention 16:17, pages 7825-7829.
Crossref
Changhoon YooDok Hyun YoonCheolwon Suh. (2014) Serum beta-2 microglobulin in malignant lymphomas: an old but powerful prognostic factor. Blood Research 49:3, pages 148.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.